IL154277A0 - Tartrate salts of thiazolidinedione derivative - Google Patents

Tartrate salts of thiazolidinedione derivative

Info

Publication number
IL154277A0
IL154277A0 IL15427701A IL15427701A IL154277A0 IL 154277 A0 IL154277 A0 IL 154277A0 IL 15427701 A IL15427701 A IL 15427701A IL 15427701 A IL15427701 A IL 15427701A IL 154277 A0 IL154277 A0 IL 154277A0
Authority
IL
Israel
Prior art keywords
tartrate salts
thiazolidinedione derivative
thiazolidinedione
derivative
tartrate
Prior art date
Application number
IL15427701A
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of IL154277A0 publication Critical patent/IL154277A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
IL15427701A 2000-08-04 2001-08-03 Tartrate salts of thiazolidinedione derivative IL154277A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0019226.0A GB0019226D0 (en) 2000-08-04 2000-08-04 Novel pharmaceutical
PCT/GB2001/003514 WO2002012233A1 (en) 2000-08-04 2001-08-03 Tartrate salts of thiazolidinedione derivative

Publications (1)

Publication Number Publication Date
IL154277A0 true IL154277A0 (en) 2003-09-17

Family

ID=9897028

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15427701A IL154277A0 (en) 2000-08-04 2001-08-03 Tartrate salts of thiazolidinedione derivative

Country Status (23)

Country Link
EP (1) EP1307448A1 (en)
JP (1) JP2004505971A (en)
KR (1) KR20030022356A (en)
CN (1) CN1458930A (en)
AP (1) AP2003002737A0 (en)
AU (1) AU2001276508A1 (en)
BG (1) BG107605A (en)
BR (1) BR0112984A (en)
CA (1) CA2417828A1 (en)
CZ (1) CZ2003314A3 (en)
EA (1) EA200300231A1 (en)
EC (1) ECSP034468A (en)
GB (1) GB0019226D0 (en)
HU (1) HUP0300770A2 (en)
IL (1) IL154277A0 (en)
MA (1) MA25830A1 (en)
MX (1) MXPA03001086A (en)
NO (1) NO20030508L (en)
OA (1) OA12355A (en)
PL (1) PL360702A1 (en)
SK (1) SK1452003A3 (en)
WO (1) WO2002012233A1 (en)
ZA (1) ZA200300962B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
FR2845602B1 (en) * 2002-10-11 2005-07-08 Servier Lab ASSOCIATION BETWEEN A LIGAND OF RECEPTORS ACTIVE BY PEROXISOME PROLIFIERS AND AN ANTIOXIDANT AGENT AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
US7264813B2 (en) * 2003-09-24 2007-09-04 Nikken Sohonsha Corporation Therapeutic uses of Dunaliella powder
CN102532122B (en) * 2010-12-29 2015-12-02 开封制药(集团)有限公司 The preparation method of Tartraric rosiglitazone

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
NO20030508D0 (en) 2003-01-31
WO2002012233A1 (en) 2002-02-14
EA200300231A1 (en) 2003-06-26
AP2003002737A0 (en) 2003-03-31
JP2004505971A (en) 2004-02-26
GB0019226D0 (en) 2000-09-27
ECSP034468A (en) 2003-03-31
SK1452003A3 (en) 2004-05-04
CZ2003314A3 (en) 2004-02-18
OA12355A (en) 2004-03-19
PL360702A1 (en) 2004-09-20
HUP0300770A2 (en) 2003-11-28
BG107605A (en) 2003-09-30
KR20030022356A (en) 2003-03-15
BR0112984A (en) 2003-06-10
AU2001276508A1 (en) 2002-02-18
CA2417828A1 (en) 2002-02-14
NO20030508L (en) 2003-03-20
MXPA03001086A (en) 2003-05-27
CN1458930A (en) 2003-11-26
EP1307448A1 (en) 2003-05-07
ZA200300962B (en) 2003-10-29
MA25830A1 (en) 2003-07-01

Similar Documents

Publication Publication Date Title
SI1686119T1 (en) Pyrimidine-5-one derivatives as LDL-PLA2 inhibitors
HK1064035A1 (en) Pharmaceutical salts of 1-phenyl-3-dimethylamino-propane compounds
HK1057359A1 (en) Tartrate salts of thiazolidinedione derivative
IL154277A0 (en) Tartrate salts of thiazolidinedione derivative
IL154275A0 (en) Tartrate salts of thiazolidinedione derivative
HUP0101875A3 (en) Process for the preparation of piperidine derivatives
HK1057360A1 (en) Tartrate salts of thiazolidinedione derivative
SI1305310T1 (en) Tartrate salts of thiazolidinedione derivative
HK1045948A1 (en) New crystalline form of omeprazole
PL340617A1 (en) Derivatives of 2-acylpyridine
SI1301469T1 (en) Preparation of 4-thioalkylbromobenzene derivatives